Meet the expert...
Jens Vogel, PH.D
Senior Vice President and Global Head of Biotech at Bayer
* Leading biologics operations, development and strategy, across 5 sites globally * PS product owner for $4bn/yr commercial biologics portfolio * Driving pipeline realization incl. cell & gene therapy industrialization * 20+ years of experience in all aspects of biopharmaceutical development and operations * Track record of building and leading high performance organizations & teams * Driver for Innovation in Technology and Business * Strong expertise in leading global CMC drug development from early development through clinical, regulatory submissions, launch and commercial supply